|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20072579
Huang et al. • Figure S1 Endogenous expression of MR1 in different mouse cell lines and tissues.
• Figure S2 Treatment of cells with leupeptin down-regulates the MR1 surface expression, impairs Ii processing, and retains MR1 in late endocytic compartments.
• Figure S3 MR1 surface expression and MAIT activation inhibited by H+ ATPase inhibitor bafilomycin A1 (Baf A1).
• Figure S4 The siRNA sequences (A-C) for mouse Ii were selected using the Whitehead siRNA server.
• Figure S5 Surface MR1 expression and MAIT cell activation with CH27.mMR1.EGFP cells.
• Figure S6 MR1 accumulates in late endocytic compartments upon CMA inhibition.
| ||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
